CorInnova
Phase 1/2With a lead investment from Wellcome Trust, CorInnova is developing a minimally invasive, non-blood contacting cardiac assist device for acute heart failure treatment. The device is intended to initially treat the large and fast-growing short-term cardiac assist market (up to 5 days’ use). It will expand this market to an $5B addressable market by treating the 50% of patients who cannot use, or are unsuitable for, existing cardiac assist devices. The device is collapsible, allowing it to be d...
About
With a lead investment from Wellcome Trust, CorInnova is developing a minimally invasive, non-blood contacting cardiac assist device for acute heart failure treatment. The device is intended to initially treat the large and fast-growing short-term cardiac assist market (up to 5 days’ use). It will expand this market to an $5B addressable market by treating the 50% of patients who cannot use, or are unsuitable for, existing cardiac assist devices. The device is collapsible, allowing it to be d...
Funding History
2Total raised: $2.5M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile